ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,083.57
0.36%
Dow Jones
44,747.63
-0.28%
US Dollar vs MXN
20.4588
-0.59%
Brent Oil
74.165
-0.56%
Bitcoin
96,589.13
-0.03%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. Medesis Pharma SA (ALMDP) Cotización

Medesis Pharma SA

Medesis Pharma SA (ALMDP)

EU
0.419
0.058
(16.07%)
Cerrado 06 Febrero 10:30AM
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
0.419
Postura de Compra
0.391
Postura de Venta
0.42
Volume Operado de la Acción
199,593
0.362 Rango del Día 0.463
0.30 Rango de 52 semanas 2.40
Capitalización de Mercado [m]
1.856M
Precio Anterior
0.361
Precio de Apertura
0.37
Hora
2000
@
0.419
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
23,471
Acciones en circulación
4,429,081
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.47
Beneficio por acción (BPA)
-0.89
turnover
300k
Beneficio neto
-3.96M

Acerca de Medesis Pharma SA

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.medesispharma.com
Sede
Montpellier, Herault, Fra
Fundado
-
Medesis Pharma SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALMDP. The last closing price for Medesis Pharma was 0.36 €. Over the last year, Medesis Pharma shares have traded in a share price range of 0.30 € to 2.40 €.

Medesis Pharma currently has 4,429,081 shares in issue. The market capitalisation of Medesis Pharma is 1.60 € million. Medesis Pharma has a price to earnings ratio (PE ratio) of -0.47.

ALMDP Últimas noticias

Más noticias

Medesis Pharma souhaite accélérer le développement de ses produits antinucléaires et fait un point sur sa stratégie

Medesis Pharma souhaite accélérer le développement de ses produits antinucléaires et fait un point sur sa stratégie Medesis Pharma souhaite accélérer le développement de ses produits...

05 Abril 2022
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.07321.0982658960.3460.4630.33474600.35763771DE
40.025.012531328320.3990.4630.324105220.36581889DE
12000.4190.5180.3234710.37511884DE
26-0.381-47.6250.820.3480530.67257494DE
52-0.377-47.36180904520.7962.40.3279390.76076402DE
156-4.181-90.89130434784.67.160.3124941.50712435DE
260-12.081-96.64812.5180.3124173.78269375DE

ALMDP - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Medesis Pharma?
El precio actual de las acciones de Medesis Pharma es 0.419 €
¿Cuántas acciones de Medesis Pharma están en circulación?
Medesis Pharma tiene 4,429,081 acciones en circulación
¿Cuál es la capitalización de mercado de Medesis Pharma?
La capitalización de mercado de Medesis Pharma es EUR 1.6M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Medesis Pharma?
Medesis Pharma ha negociado en un rango de 0.30 € a 2.40 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Medesis Pharma?
El ratio precio/beneficio de Medesis Pharma es -0.47
¿Cuál es el ratio de efectivo a ventas de Medesis Pharma?
El ratio de efectivo a ventas de Medesis Pharma es 6.2
¿Cuál es la moneda de reporte de Medesis Pharma?
Medesis Pharma presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Medesis Pharma?
El último ingresos anual de Medesis Pharma es EUR 300k
¿Cuál es el último beneficio anual de Medesis Pharma?
El último beneficio anual de Medesis Pharma es EUR -3.96M
¿Cuál es la dirección registrada de Medesis Pharma?
La dirección registrada de Medesis Pharma es L'OREE DES MAS AVENUE DU GOLF, MONTPELLIER, HERAULT, 34670
¿Cuál es la dirección del sitio web de Medesis Pharma?
La dirección del sitio web de Medesis Pharma es www.medesispharma.com
¿En qué sector industrial opera Medesis Pharma?
Medesis Pharma opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALCYBCybergun
0.0002 €
(100.00%)
12.48M
MLWEYWeya
0.027 €
(68.75%)
2k
ALENTEntreparticuliersCom
0.75 €
(52.13%)
90.71k
GIM32Gimv NV
0.65 €
(37.71%)
477.35k
ALSASStradim Espac Fin
6.90 €
(33.98%)
2k
CLEXCumulex NV
0.585 €
(-55.68%)
738
SOISOITEC
57.70 €
(-29.72%)
1.92M
TUVDSBio UV Group DS
0.0231 €
(-29.36%)
620.29k
ALALOAcheterLouerFR
0.0227 €
(-29.06%)
2.7M
MLOCTOctopus Biosafety
0.144 €
(-25.39%)
10.36k
ATOAtos SE
0.0021 €
(0.00%)
402.51M
ALVERVergnet
0.0007 €
(-22.22%)
70.45M
BCPBanco Comercial Portugues SA
0.5066 €
(2.76%)
50.03M
INGAING Groep NV
15.92 €
(-0.29%)
22.66M
ALNRGEnergisme SA
0.0037 €
(12.12%)
17.17M

Discusión

Ver feed completo
B402 B402 3 minutos hace
Did dems want electric cars? Was anyone producing them in quantity in the us before? Do they compete with some of the fastest cars? As I remember people said it couldn't be done yet........Self driving?

Then on to Reusable rockets? Record number of launches..........World wide intern
rosemountbomber rosemountbomber 3 minutos hace
Raggy, not selling my AMRN as of yet, but looking at targets for a bunch of others that we may havd in common.  Took some off the table in CRMD at 14 and wondering if I should have unloaded all. In CADL and a wee bit apprehensive over the next readout in pancreatic (its a bear) so looking to take so
AMRN BCRX CADL
jog49 jog49 3 minutos hace
I wholeheartedly agree but Golfbum does have the experience. LOL!
FNMA
janice shell janice shell 3 minutos hace
Good. I hope hundreds of thousands more do the same thing.
DewDiligence DewDiligence 3 minutos hace
RANI—The relative bioavailability of oral semaglutide was 107% versus subcutaneous administration. I simply don't believe that statistic is genuine.
capgain capgain 4 minutos hace
That was cool, never seen that before and never heard of the First Edition.
janice shell janice shell 4 minutos hace
No, he did not. And even if he had, that would not have made it okay for Trump to do it.

We do know Trump lied more than 30,000 times during his first term; the Washington Post kept count. I very much doubt that record will ever be broken, except, perhaps, by Trump himself.
Jetmek_03052 Jetmek_03052 5 minutos hace
Nothing to say about the point of my post, little Jimmy boy?

Your compatriot Sylvia just told a bald-faced lie. She basically said that it was OK that POOR WITTLE DBMM was down....because "all the blue chip stocks were down bad this week".

I just proved she was not tel
DBMM
Seminole Red Seminole Red 5 minutos hace
Treasury Secretary Scott Bessent wants to bypass the Fed to lower interest rates

https://www.msn.com/en-us/news/politics/treasury-secretary-scott-bessent-wants-to-bypass-the-fed-to-lower-interest-rates/ar-AA1yygYQ?ocid=msedgntp&pc=HCTS&cvid=9f4f80ffa16d42ce8b5c9382c973dd54&ei=36
I-Glow I-Glow 5 minutos hace
Pillsworth lied about the $20,000 - first he said it was a DTCC Advisory fee - then he said it is a $20,000 MM advisory fee.

It would be illegal for a MM to be paid and the DTCC fees are closer to $2000.

Pillsworth needs to be removed as the CEO.

IG
CCTL
Jim Beem Jim Beem 5 minutos hace
that's called dilution
ASII
docj docj 5 minutos hace
One wonders if CYDY/GSK are in talks:

From doit4dale on Stocktwits. Look at what Emma just said:

Chief Executive Officer (CEO) Emma Walmsley said the company lifted its 2031 estimate as the company is "increasing and prioritizing R&D investment to promising new long-act
CYDY
ITYS ITYS 5 minutos hace
One needs only to chuckle when bashers bring up a P n D, what's in MGON float 250M ?
Now I could see if was a billion shares or 2 billion and most certainly if some ridiculous issued like 5 billion, but 250M ??

C'mon they need to be better ! They are not even being entertaining
MGON
mick mick 5 minutos hace
yes thank you, i was going to thomas
TMaga TMaga 6 minutos hace
The patent was not reinstated and HCMC did not pursue it. They dropped the case against PM and did not reapply to get the patent legal again.
HCMC
splintered sunlight splintered sunlight 6 minutos hace
Incredibly problematic...
ARAT
xxxx xxxx 6 minutos hace
pizza... pizza

we wait

with INTELLIGENT DD

Colorado ?

We can split it,

E/w
N/s

What works?
SHIBUSD
ShawnP123 ShawnP123 7 minutos hace
Many of you will like this if you haven't already been made aware of.
https://www.yahoo.com/finance/video/deepseeks-advanced-tracking-technology-never-222053515.html
NVDA
jimr1717 jimr1717 8 minutos hace
Zzzzz .03, .02, .01, .001
IFUS
rosemountbomber rosemountbomber 8 minutos hace
Capt, I really am not knowledgeable enough to say one way or another and so my thought that it gets denied is a guess.  But what really irks me is the delay.  There is no new information that was discovered since the Fed Appeal decision so this nothing but a delay tactic.  It is one thing for things
AMRN
joe botts joe botts 8 minutos hace
Good one
Calvin Hobbes Calvin Hobbes 8 minutos hace
Yes this is going to a dollar plus very soon. IMHO
MGOL
Louie_Louie Louie_Louie 9 minutos hace
Folks....These appointments and the people involved in re-list/release have been strategically working on this for months and months in the background, hidden away. Trump only needs all his chess pieces in place. Have you noticed how he stirs the pot to misdirect Democrats? While he has those app
urge2surge urge2surge 9 minutos hace
Keep an eye on the dtc vs unrestricted imbalance. He's already used up the previously rescinded shares. Will see if he uses a part of the 2.5 to pay off debts. The current market cap is 480k, minus debts is 250k.
The principal fiduciary duties of a CEO are ROI to shareholders. At current mc,
IDVV

Su Consulta Reciente

EU
ALMDP
Medesis Pharma
BIT
UB7XM6
Unicredit Bank
BIT
S30629
Societe Generale Effekten
BIT
XDER
Db X-tftse E/n Dere1c
BIT
TIT
Telecom Italia
BIT
P1L026
BNP Paribas Issuance
BIT
UIJ456
Unicredit Bank
BIT
P1DAK4
BNP Paribas Issuance
BIT
P1S9A2
BNP Paribas Issuance
NYSE
MHNC
Maiden Holdings North Am...
KOSPI
002900
TYM
BIT
P04639
Bnp Paribas Issuance
NASDAQI
XMS1
Settlement NASDAQ 100 Mini
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios